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Tables 1 and 2.resistant S. aureus isolates with clindamycin may
lead to clinical failure.8,9 In the present study, 19.1%
of S. aureus (19% in MRSA and 19.2% in MSSA) were
inducible clindamycin-resistant. A similar type of
study in two different hospitals in Chicago, USA
revealed 7% and 12% inducible clindamycin resis-
tance for MRSA and MSSA respectively.10 However
there are no data currently available to compare the
results in India. In addition, 25% of S. aureus isolates
(23.8% in MRSA and 25.6% in MSSA) were erythro-
mycin-resistant, clindamycin-susceptible and D test
negative, probably indicating an efflux pump
mediated mechanism (non-inducible) that needs
further study. This is a preliminary report; further
studies and follow-up on larger numbers of isolates
have to be undertaken to determine the relationship
between methicillin and macrolide resistance
among S. aureus. Performing the D test on a routine
antibiotic susceptibility plate would detect the
inducible clindamycin resistance early in S. aureus.
In addition, it also provides the possible status of
non-inducible isolates where clindamycin may be an
important therapeutic option.7—9
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acic surgery in Iran
The use of standardized definitions for nosocomial
infections allows meaningful comparison of surveil-
lance data between hospitals,1 and between coun-
tries. We used the definitions and methodologies of
the CDC’s National Nosocomial Infection Surveil-
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intensive care units (ICU) at two university hospitals
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Three major device-associated hospital-
acquired infections were selected for analysis:
urinary tract infection (UTI), ventilator-associated
pneumonia (VAP), and catheter-associated blood-
stream infection (BSI). Data from 478 patients
undergoing cardiac surgery and admitted to the
ICU during the period 1 March 2000 to 31 August
2000 were prospectively collected and analyzed.
A total of 4.1 device-associated infections per 1000
patient-days were documented; individual infec-
tion rates and device utilization rates are shown in
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Table 2 Device utilization ratio and comparison to NNIS results.4
Device
utilization ratio
NNIS percentiles
10th 25th 50th 75th 90th
Urinary catheter 0.54 0.70 0.80 0.90 0.95 0.97
Central line 0.60 0.56 0.69 0.82 0.90 0.95
Ventilator 0.54 0.31 0.38 0.47 0.54 0.63
NNIS, National Nosocomial Infection Surveillance System.
Table 1 Incidence rates of NIs and comparison to NNIS results.4
Number
of NIs
Device-days NI rate per 1000
device-days
NNIS percentiles
10th 25th 50th 75th 90th
UTI 4 1586 2.9 0.5 1.1 2.5 3.8 5.5
BSI 3 1753 1.7 0.9 1.5 2.4 3.6 4.7
VAP 5 1586 3.2 2.9 5.5 9.5 13.2 17.2
Total observed patient-days = 2943. NI, nosocomial infection; NNIS, National Nosocomial Infection Surveillance System; UTI, urinary
tract infection; BSI, catheter-associated bloodstream infection; VAP, ventilator-associated pneumonia.The ease of access to the internet and the
increased use of NNIS standards4 permit hospitals
in different countries to benchmark their perfor-
mance alongside hospitals in Europe and North
America.
Our study is the first to look at ICU utilization
and hospital-acquired infection rates in Iran,
although data from other Middle East countries
have been previously reported. Among 337 Israeli
adult general ICU patients, Finkelstein and collea-
gues documented rates for VAP, BSI, and UTI of 20
per 1000 ventilator-days, 12 per 1000 central iv
catheter-days, and 14 per 1000 indwelling urinary
catheter-days, respectively.5 In Saudi Arabia,
Memish and co-workers demonstrated a VAP rate
of 16.8 infections per 1000 days of mechanical
ventilation.6
Among cardiothoracic ICU patients, our low urin-
ary catheter utilization but high UTI incidence
suggests a nosocomial problem that needs addres-
sing. In contrast, we found a low rate of VAP,
ranging between the 10th and 25th percentile
compared to NNIS data, even though our rate of
ventilator utilization was above the 75th percentile
in the USA.
Three national surveillance systems for hospital-
acquired infections, all based on the NNIS model,
have been developed independently, and success-
fully implemented, in England, Germany, and the
Netherlands.7 Further standardization of case-find-
ing methods, minimum data sets, and data analysis
and resolution of differences in the definitions of
infection, study populations, and follow-up shouldmake international comparison of nosocomial infec-
tions easier. Such comparisons will help physicians
identify differences in healthcare practices
between countries, suggest areas for improvement,
and help implement much-needed hospital infec-
tion control measures.
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